Business Description
Acerus Pharmaceuticals Corp
NAICS : 325412
SIC : 3741
ISIN : CA00444G1081
Compare
Compare
Traded in other countries / regions
ASP.Canada3TP0.Germany IPO Date
2009-09-03Description
Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -87.59 | |||||
| 12-1 Month Momentum % | -95.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -915.38 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Acerus Pharmaceuticals Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 3.92 | ||
| EPS (TTM) (C$) | -4.169 | ||
| Beta | 0 | ||
| Volatility % | 78.79 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (C$) | 0 | ||
| 20-Day SMA (C$) | 0 | ||
| 12-1 Month Momentum % | -95.5 | ||
| 52-Week Range (C$) | 0.275 - 10 | ||
| Shares Outstanding (Mil) | 7.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Acerus Pharmaceuticals Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Acerus Pharmaceuticals Corp Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Acerus Pharmaceuticals Corp Frequently Asked Questions
What is Acerus Pharmaceuticals Corp(TSX:ASP)'s stock price today?
The current price of TSX:ASP is C$0.36. The 52 week high of TSX:ASP is C$10.00 and 52 week low is C$0.28.
When is next earnings date of Acerus Pharmaceuticals Corp(TSX:ASP)?
The next earnings date of Acerus Pharmaceuticals Corp(TSX:ASP) is .
Does Acerus Pharmaceuticals Corp(TSX:ASP) pay dividends? If so, how much?
Acerus Pharmaceuticals Corp(TSX:ASP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers